stocks prices, charts & quotes

Free Stock Prices, Charts & Stock Price Quotes

Symbol Search Browse Symbols My Charts Menu
F.A.Questions Suggestion Box Advertising Info Commodity Charts Forex Markets

Stocks & Financial News

Breaking financial news 24/7 courtesy of Inc. / TFC Commodity Charts

Pfizer Inc (PFE) Crosses Pivot Point Support at $32.59

Jun 24, 2020 (SmarTrend(R) News Watch via COMTEX) --
Shares of Pfizer Inc (NYSE:PFE) have bearishly opened below the pivot of $32.92 today and have reached the first support level of $32.59. Should the shares continue to fall, the support pivots of $32.41 and $31.90 will be of interest.

In the past 52 weeks, Pfizer Inc share prices have been bracketed by a current low of $0.00 and a high of $44.56 and are now at $0.00. Over the past week, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has declined 0.5%.

There is potential upside of 0.0% for shares of Pfizer Inc based on a current price of $0.00 and an average consensus analyst price target of $39.71. Pfizer Inc shares should first meet resistance at the 50-day moving average (MA) of $36.37 and find additional resistance at the 200-day MA of $36.52.

SmarTrend is tracking the current trend status for Pfizer Inc and will alert subscribers who have PFE in their portfolio or watchlist when shares have changed trend direction.

Write to SmarTrend at


SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at:

comtex tracking

Do not sell my personal information

Copyright © 2020. All market data is provided by Barchart Solutions. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.